Staging classification of lung cancer. A critical evaluation.
暂无分享,去创建一个
[1] V. Rusch,et al. Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. , 2000, The Journal of thoracic and cardiovascular surgery.
[2] C. Mountain,et al. Regional lymph node classification for lung cancer staging. , 1997, Chest.
[3] R. Coleman,et al. Proceedings of a National Cancer Institute workshop: PET in oncology--a clinical research agenda. , 1994, Radiology.
[4] H. Groen,et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.
[5] H. Koeffler,et al. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. , 2001, Cancer research.
[6] R. Coleman,et al. PET in lung cancer. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] D. Ferrigno,et al. Prognostic value of stage grouping and TNM descriptors in lung cancer. , 2000, Chest.
[8] K. O'Byrne,et al. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer , 2000, British Journal of Cancer.
[9] T. Naruke,et al. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. , 1978, The Journal of thoracic and cardiovascular surgery.
[10] K. Yasumoto,et al. Postoperative prognosis in patients with non-small cell lung cancer with synchronous ipsilateral intrapulmonary metastasis. , 1997, The Annals of thoracic surgery.
[11] S. Miyoshi,et al. Surgical results for small cell lung cancer based on the new TNM staging system. Thoracic Surgery Study Group of Osaka University, Osaka, Japan. , 2000, The Annals of thoracic surgery.
[12] S. Adak,et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. , 2000, The New England journal of medicine.
[13] C. Angeletti,et al. Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL -2-mediated neovascularization , 2000, British Journal of Cancer.
[14] Y. Morishita,et al. Mediastinal lymph node evaluation by computed tomographic scan in lung cancer. , 2001, The Journal of cardiovascular surgery.
[15] Tzei-Yi Lin,et al. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. , 2001, Cancer research.
[16] Harvey I. Pass,et al. Lung cancer : principles and practice , 1996 .
[17] J. Howington,et al. Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. , 2000, The Annals of thoracic surgery.
[18] G. V. von Schulthess,et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. , 1998, The Annals of thoracic surgery.
[19] T. Abe,et al. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] M. Riggs,et al. Effect of HER2/neu expression on survival in non-small-cell lung cancer. , 2001, Clinical lung cancer.
[21] G. Silvestri,et al. Diagnosis and staging of lung cancer. , 2000, Clinics in chest medicine.
[22] D. Fuchs,et al. Neopterin: a prognostic variable in operations for lung cancer. , 2000, The Annals of thoracic surgery.
[23] W. Richards,et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. , 2000, The Annals of thoracic surgery.
[24] Max H. Myers,et al. Manual for Staging of Cancer , 1992 .
[25] P Grenier,et al. CT demonstration of the 1996 AJCC-UICC regional lymph node classification for lung cancer staging. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.
[26] Non-small cell lung cancer: FDG-PET imaging. , 1999, Journal of thoracic imaging.
[27] D. Carter. TNM Classification of Malignant Tumors , 1998 .
[28] F MURRAY,et al. Diagnosis and treatment of lung cancer. , 1955, Geriatrics.
[29] J. Roth,et al. Gene replacement strategies for treating non-small cell lung cancer. , 2000, Seminars in radiation oncology.
[30] R. Livingston,et al. [A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer]. , 2001, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.
[31] H. Hansen,et al. Surgery in limited stage small cell lung cancer. , 1999, Cancer treatment reviews.
[32] S. Kondo,et al. Evaluation of new TNM lung cancer classification. , 2000, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.
[33] L. Dominioni,et al. Stage I nonsmall cell lung carcinoma , 2000, Cancer.
[34] J. Vansteenkiste,et al. Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease). , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[35] H. Wada,et al. Prognostic significance of polysialic acid expression in resected non-small cell lung cancer. , 2001, Cancer research.
[36] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[37] B. Thompson,et al. MR imaging of pulmonary and mediastinal malignancies. , 2000, Magnetic resonance imaging clinics of North America.
[38] M. Green,et al. The 1997 International Staging System for non-small cell lung cancer: have all the issues been addressed? , 1999, Chest.
[39] P C Goodman,et al. Staging non-small cell lung cancer with whole-body PET. , 1999, Radiology.
[40] C. Mountain,et al. A new international staging system for lung cancer. , 1987, Chest.
[41] D. Harpole,et al. Staging techniques for lung cancer. , 2000, Chest surgery clinics of North America.
[42] P. Valk,et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. , 2000, The Annals of thoracic surgery.
[43] J. Luketich,et al. The role of positron emission tomography in evaluating mediastinal lymph node metastases in non-small-cell lung cancer. , 2001, Clinical lung cancer.
[44] J. Deslauriers,et al. Carcinoma of the lung. Evaluation of satellite nodules as a factor influencing prognosis after resection. , 1989, The Journal of thoracic and cardiovascular surgery.
[45] Y. Nishiwaki,et al. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. , 1999, The Journal of thoracic and cardiovascular surgery.
[46] O. Stoeltzing,et al. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer , 2000, British Journal of Cancer.
[47] S. Berlangieri,et al. Metabolic staging of lung cancer. , 2000, The New England journal of medicine.
[48] E. Patz,et al. Lung cancer and positron emission tomography with fluorodeoxyglucose. , 2000, Lung cancer.
[49] L. Kostakoglu,et al. Nuclear medicine imaging of lung cancer. , 2000, Radiologic clinics of North America.
[50] Y. Nishiwaki,et al. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. , 1999, The Journal of thoracic and cardiovascular surgery.
[51] Beahrs Oh,et al. The American Joint Committee on Cancer. , 1984 .
[52] C. Mountain. Surgical treatment of lung cancer , 1991 .
[53] V. Zoumpourlis,et al. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics. , 2001, Cancer research.
[54] M. O'Doherty,et al. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. , 1999, The Annals of thoracic surgery.
[55] P. Zanen,et al. Survival in synchronous vs. single lung cancer: upstaging better reflects prognosis. , 2000, Chest.
[56] V. Capelozzi,et al. Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas. , 2000, Japanese journal of clinical oncology.